Search research articles
Contact Us
Filters
Showing results (111-120 of 162) with videos related to
Page
of 17
Sort By:
Stroke
|
May 16, 2009
Recombinant T cell receptor ligand treats experimental stroke
Sandhya Subramanian, Bing Zhang, Yasuharu Kosaka, et al.
Metabolic Brain Disease
|
June 20, 2018
Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells
Hilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Journal of Neuroscience Research
|
December 13, 2002
Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice
Agata Matejuk, Abigail C Buenafe, Jami Dwyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation
Chunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
Metabolic Brain Disease
|
October 15, 2013
A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke
Gil Benedek, Wenbin Zhu, Nicole Libal, et al.
European Journal of Immunology
|
April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects
Gil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
The American Journal of Pathology
|
December 8, 2004
T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis
Magdalena J Polanczyk, Richard E Jones, Sandhya Subramanian, et al.
The American Journal of Pathology
|
September 26, 2003
The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha
Magdalena Polanczyk, Alex Zamora, Sandhya Subramanian, et al.
Cellular Immunology
|
October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 30, 2009
Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right
Carl E Ruby, Melissa A Yates, Daniel Hirschhorn-Cymerman, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 162) with videos related to
Sort By:
Page
of 17
Stroke
|
May 16, 2009
Recombinant T cell receptor ligand treats experimental stroke
Sandhya Subramanian, Bing Zhang, Yasuharu Kosaka, et al.
Metabolic Brain Disease
|
June 20, 2018
Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells
Hilary A Seifert, Gil Benedek, Ha Nguyen, et al.
Journal of Neuroscience Research
|
December 13, 2002
Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice
Agata Matejuk, Abigail C Buenafe, Jami Dwyer, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 7, 2003
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation
Chunhe Wang, Jeffery L Mooney, Roberto Meza-Romero, et al.
Metabolic Brain Disease
|
October 15, 2013
A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke
Gil Benedek, Wenbin Zhu, Nicole Libal, et al.
European Journal of Immunology
|
April 12, 2013
Partial MHC class II constructs inhibit MIF/CD74 binding and downstream effects
Gil Benedek, Roberto Meza-Romero, Shayne Andrew, et al.
The American Journal of Pathology
|
December 8, 2004
T lymphocytes do not directly mediate the protective effect of estrogen on experimental autoimmune encephalomyelitis
Magdalena J Polanczyk, Richard E Jones, Sandhya Subramanian, et al.
The American Journal of Pathology
|
September 26, 2003
The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha
Magdalena Polanczyk, Alex Zamora, Sandhya Subramanian, et al.
Cellular Immunology
|
October 5, 2021
Brief report: Enhanced DRα1-mMOG-35-55 treatment of severe EAE in MIF-1-deficient male mice
Arthur A Vandenbark, Roberto Meza-Romero, Jack Wiedrick, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 30, 2009
Cutting Edge: OX40 agonists can drive regulatory T cell expansion if the cytokine milieu is right
Carl E Ruby, Melissa A Yates, Daniel Hirschhorn-Cymerman, et al.
Page
of 17